Scarica l'app Stockscreener
28.23
0.28%
0.08
Dopo l'orario di chiusura:
28.23
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call - Yahoo Finance
Fuller & Thaler (NASDAQ: COLL) reports 5.03% beneficial stake in common stock - Stock Titan
COLLEGIUM PHARMACEUTICAL INC : NEEDHAM CUTS TARGET PRICE TO $46 FROM $56 - webull.com
Can Collegium Pharmaceutical (NASDAQ:COLL) Rebound From Its Yearly Low? - Kalkine Media
Collegium Pharmaceutical Initiates $50 Million Accelerated Share Buyback with Jefferies LLC - Kalkine Media
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com India
Why is Collegium Pharmaceutical stock climbing today? By Investing.com - Investing.com Canada
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program - citybiz
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Nigeria
Collegium gains on $50M accelerated share buyback program - Seeking Alpha
Collegium Pharmaceutical to repurchase $50 million in stock - Investing.com
Collegium Pharmaceutical launches $50M accelerated share repurchase under $150M buyback program - TradingView
Collegium Announces $50 Million Accelerated Share Repurchase Program - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year LowTime to Sell? - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Shares Down 6.5%Here's What Happened - MarketBeat
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance - Yahoo Finance
Collegium Pharmaceutical, Inc. Revenue Breakdown – NASDAQ:COLL - TradingView
Collegium Pharmaceutical (COLL) Stock Revenue Growth Masks Deepening Margin Squeeze - Sahm
Collegium Pharmaceutical (NASDAQ:COLL) Cut to "Hold" at Wall Street Zen - marketbeat.com
Collegium Pharmaceutical (NASDAQ:COLL) Releases Earnings Results, Beats Estimates By $0.20 EPS - MarketBeat
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $43 - Moomoo
Collegium Pharmaceutical (COLL) Stock May Trade At A Discount Even After A 60% Return - simplywall.st
Piper Sandler Reiterates Neutral Rating for Collegium Pharmaceutical (NASDAQ:COLL) - MarketBeat
Is Now The Time To Put Collegium Pharmaceutical (NASDAQ:COLL) On Your Watchlist? - moomoo.com
Collegium Pharmaceutical, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:COLL) 2026-08-07 - Seeking Alpha
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Unveiling an 82.76% Potential Upside - DirectorsTalk Interviews
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 1-Year Low Following Analyst Downgrade - MarketBeat
Collegium Pharmaceutical, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Collegium Pharmaceutical stock hits 52-week low at 30.11 USD - Investing.com
Collegium Pharmaceutical, Inc. Stock 12‑Month Price Target Cut to $51.2, Implies 43% Upside - TradingView
Needham & Company LLC Cuts Collegium Pharmaceutical (NASDAQ:COLL) Price Target to $46.00 - MarketBeat
Collegium Pharmaceutical Releases Q2 2026 Financial Results - AlphaStreet
Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap DownShould You Sell? - MarketBeat
Collegium Pharmaceutical Down Over 13%, On Track for Largest Percent Decrease Since May 2024 -- Data Talk - Moomoo
Collegium Pharmaceutical (COLL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Collegium Pharmaceutical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Collegium Pharmaceutical Q2 Earnings Call Highlights - MarketBeat
Collegium Pharmaceutical falls 13% on weak revenue guidance By Investing.com - Investing.com South Africa
Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops - Yahoo Finance
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Collegium Pharmaceutical: Q2 Earnings Snapshot - marketscreener.com
Collegium Pharmaceutical Reports Q2 2026 Results, Completes AZSTARYS Acquisition and Raises Full-Year Guidance - Quiver Quantitative
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress - Yahoo Finance
Collegium Pharmaceutical, Inc. $COLL Shares Acquired by Sei Investments Co. - MarketBeat
Collegium Pharmaceutical (COLL): Principal Global Investors discloses 5% equity stake - Stock Titan
Collegium Pharmaceutical earnings ahead after ADHD acquisition By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect - Barchart.com
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo! Finance Canada
Janus Henderson Group PLC Increases Stock Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium Pharma shifts focus to ADHD growth wi... - Pluang
Vanguard Capital Management (COLL) discloses 5.01% passive stake in Collegium - Stock Titan
0.79%
5.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):